For example, c-MYC was recently reported to increase the intracellular labile iron pool by repressing the expression of FTH1, which is part of the cellular iron storing protein ferritin, and by stimulating the expression of the iron regulatory protein-2 (IRP2), which enhances iron influx to cancer cells 6. This evidence concerns the gene IREB2 and cancer.